Kewpie (2809.T) Earnings Analysis

Kewpie (2809.T) next reports earnings on 2026-10-01, consensus EPS 45.14 JPY. Last quarter (2026-07-09) it beat with EPS 56.99 JPY vs 37.29 JPY est (+52.8%). It has beaten estimates in 2/8 recent quarters (25%). Trailing P/E 24.69.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 2809.T next report earnings?

Next earnings date2026-10-01
Consensus EPS estimate45.14 JPY
Revenue estimate135.83B

2809.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-0956.99 JPY37.29 JPY+52.8%Beat
2026-04-0938.96 JPY49.13 JPY-20.7%Miss
2026-01-1432.73 JPY38.95 JPY-16%Miss
2025-10-0153.69 JPY63.57 JPY-15.5%Miss
2025-07-0343.35 JPY46.57 JPY-6.9%Miss
2025-04-0388.74 JPY102.78 JPY-13.7%Miss
2025-01-0811.97 JPY16.6 JPY-27.9%Miss
2024-10-0352.11 JPY46 JPY+13.3%Beat

Beat rate: 2/8 (25%) over reported quarters with consensus data.

2809.T valuation and analyst view

Trailing P/E24.69
Trailing EPS181.55 JPY
Price / book1.88
Dividend yield1.43%
Market cap622.44B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Kewpie (2809.T)'s next earnings date?

Kewpie is next scheduled to report on 2026-10-01, with a consensus EPS estimate of 45.14 JPY and revenue estimate of 135.83B.

Did 2809.T beat earnings last quarter?

In its 2026-07-09 report, 2809.T posted EPS of 56.99 JPY versus a 37.29 JPY estimate — a beat of 52.8%.

What is 2809.T's earnings track record?

Over the last 8 reported quarters with consensus data, 2809.T beat estimates 2 times (25%).

What is 2809.T's current P/E ratio and EPS?

2809.T trades at a trailing P/E of 24.69 on trailing EPS of 181.55390735424834 JPY.

What do analysts rate 2809.T?

2809.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.